Sebastian Oltean

11PUBLICATIONS
12CO-AUTHORS
HaematologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Down-Regulation of Proline Rich Homeodomain/Haematopoietically Expressed Homeobox Expression in Prostate Cells Enables Tumour Initiation and Tumour Growth.

|Mar 27, 2026
Splice Isoforms of the Apoptosis Gene BCL-X Have Opposing Effects in Diabetic Kidney Disease: Potential Treatment Target and Prognostic Value.

Megan Stevens, Monica L Ayine, Kim Gooding

|Nov 27, 2025
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model.

Grace Martin, Ka Ying Lee, Christopher Roberts

|Apr 26, 2025
Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies.

Duygu Duzgun, Sebastian Oltean

|Nov 25, 2023
Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics.

Ling Li, Jinxia Zheng, Sebastian Oltean

|May 04, 2021
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties.

Eleanor Star, Megan Stevens, Clare Gooding

Pageof 2

Frequent Collaborators

2 joint publications

Megan Stevens

2 joint publications

David O Bates

2 joint publications

Kevin Gaston

2 joint publications

Padma-Sheela Jayaraman